What is New in Idiopathic Pulmonary Fibrosis?
What is New in Idiopathic Pulmonary Fibrosis?

What is New in Idiopathic Pulmonary Fibrosis?

  • View
    160

  • Download
    5

Embed Size (px)

Text of What is New in Idiopathic Pulmonary Fibrosis?

  • The Albert J. Finestone, M

    .D.

    Offi ce for C

    ontinuing M

    edical Education

    Temple University School of M

    edicine

    3440 N. Broad Street, Kresge 100

    Philadelphia, PA 19140

    VISIT

    OUR W

    EBSITE www.tem

    ple.edu/cm

    e

    Shar

    e th

    is b

    roch

    ure

    wit

    h

    you

    r co

    lleag

    ues

    an

    d o

    ther

    h

    ealt

    hca

    re p

    rofe

    ssio

    nal

    s

    NON-PRO

    FIT ORG

    .U.S. POSTAG

    E

    PAID

    PERM

    IT NO. 226

    PHILAD

    ELPH

    IA, PA

    What Is NeW IN IdIoPathIc PulMoNary FIbrosIs?

    2013

    WedNesday, october 23, 20136:30-8:30 PM

    locatIoN: thepalmrestaurant2801pacificavenueatlanticcity,NJ08401

    Guest sPeaKer: KevinBrown,mD,NationalJewishhealth,Denver,co

    PreseNted by: templeUniversitySchoolofmedicine

    Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

    taRget audience:Pulmonologists, Primary Care Physicians, Respiratory Therapists, Physician Assistants, Nurse Practitioners, and Nurses involved in the treatment of IPF

    leaRning obJectives:After the completion of this activity, participants should be able to:

    Explain the role of evidence-based guidelines in the diagnosis of IPF

    Describe pharmacologic and non-pharmacologic approaches to treating IPF

    Discuss the importance of patient lifestyle management tools

    Discuss various health related quality of life (QOL) measures used in IPF clinical trials with respect to patient outcomes

    accReditation statement:Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

    ceRtiFication statement:Temple University School of Medicine designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    disclosuRe policy:It is the policy of the Temple University School of Medicine, The Albert J. Finestone, M.D., Offi ce for Continuing Medical Education that the speaker and provider disclose real or apparent confl icts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Temple University School of Medicine, Offi ce for Continuing Medical Education has established policies in place that will identify and resolve all confl icts of interest prior to this educational activity. Detailed disclosure will be made prior to the activity. WedNesday, october 23, 2013

    2801pacificavenueatlanticcity,NJ08401

    2 AMA PRA Category 1 Credits

  • RegistRation FoRm

    What is neW in idiopathic pulmonaRy FibRosis?

    RegistRation is FRee. seating is limited RegistRation is RequiRed complimentaRy valet paRking

    RetuRn to:Chris Rausch Office for Continuing Medical Education Temple University School of Medicine 3440 N. Broad Street, Kresge 100 Philadelphia, PA 19140 215-707-4787 or 800-23-TUCME or FAX 215-707-8268 Register online at www.temple.edu/cme

    How did you hear about this program?

    Name:

    Degree:

    Specialty:

    aDDreSS:

    city: State: Zip:

    DaytimephoNe:

    email:

    If you have special needs that we can address to make your participation more meaningful and enjoyable, please contact our office at (215) 707-4787.

    Faculty:

    Kevin K. Brown, MDProfessor and Vice ChairmanDepartment of MedicineNational Jewish HealthDenver, CO

    Gerard Criner, MDChair, Department of Medicine Professor of MedicineDirector, Division of Pulmonary and Critical Care MedicineTemple University School of Medicine

    Irene Swift, MDAssistant Professor of MedicinePulmonary and Critical Care MedicineTemple University School of Medicine

    Yoshiya Toyoda, MDProfessor of SurgeryCardiothoracic SurgeryTemple University School of Medicine

    Michelle Vega-Olivo, MSN, CRNP, FNP-BCPulmonary Nurse PractitionerTemple Lung Center

    pRogRam agenda:

    6:15 6:25 PM Registration and Dinner

    6:25 6:30 PM Introductory RemarksGerard Criner, MD

    6:30 6:55 PM Diagnosing IPF Based on Evidence-Based Guidelines Irene Swift, MD

    6:55 7:25 PM Pharmacologic and Non-Pharmacologic Approach to Treating IPF Kevin K. Brown, MD

    7:25 7:45 PM Patient Lifestyle Management ToolsMichelle Vega-Olivo, MSN, CRNP, FNP-BC

    7:45 8:15 PM Management of Advanced-Stage DiseaseYoshiya Toyoda, MD

    8:15 8:30 PM Roundtable Discussion and Q&AGerard Criner, MD

    8:30 PM Adjourn

    What Is NeW IN IdIoPathIc PulMoNary FIbrosIs?

    2013